Description
DECREASE FOR PO#630C00033
Base award description: URINE DRUG TESTING OPTION 3 FUNDING
Modification chain · 7 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-10-01+$482,871= $482,871
- Mod P000012020-03-12+$17,823= $500,694
- Mod P000022021-04-02-$25,874= $474,820
- Mod P000032022-02-01-$28,596= $446,225
- Mod P000042022-06-07-$49,608= $396,617
- Mod P000052022-06-21-$13,514= $383,102
- Mod P000062023-10-13-$66,005= $317,097
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-10-01 | +$482,871 | $482,871 | URINE DRUG TESTING OPTION 3 FUNDING |
| Mod P00001· FUNDING ONLY ACTION | 2020-03-12 | +$17,823 | $500,694 | 36C24220N0189-URINE DRUG TESTING-INCREASE PO FOR ADDITIONAL TESTS |
| Mod P00002· CLOSE OUT | 2021-04-02 | −$25,874 | $474,820 | 36C24220N0189-URINE DRUG TESTING-INCREASE PO FOR ADDITIONAL TESTS |
| Mod P00003· FUNDING ONLY ACTION | 2022-02-01 | −$28,596 | $446,225 | 36C24220N0189-URINE DRUG TESTING-INCREASE PO FOR ADDITIONAL TESTS |
| Mod P00004· FUNDING ONLY ACTION | 2022-06-07 | −$49,608 | $396,617 | 36C24220N0189-URINE DRUG TESTING-INCREASE PO FOR ADDITIONAL TESTS |
| Mod P00005· FUNDING ONLY ACTION | 2022-06-21 | −$13,514 | $383,102 | DECREASE FOR PO#620C00645 |
| Mod P00006· FUNDING ONLY ACTION | 2023-10-13 | −$66,005 | $317,097 | DECREASE FOR PO#630C00033 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI F2M1AR1XN893)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24W25P0089 | RPO WEST (36C24W) · 6530 · HOSPITAL FURNITURE, EQUIPMENT, UTENSILS, AND SUPPLIES | $73,560 | FY2025 |
| 36C25925N0629 | NETWORK CONTRACT OFFICE 19 (36C259) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $12,859 | FY2025 |
| 36C25925N0603 | NETWORK CONTRACT OFFICE 19 (36C259) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $12,859 | FY2025 |
| 36F79725D0223 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $0 | FY2025 |
| 36C25925N0465 | NETWORK CONTRACT OFFICE 19 (36C259) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $12,874 | FY2025 |
| 36C25725P0134 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $131,000 | FY2025 |
Other recipients under Q301 from 242-NETWORK CONTRACT OFFICE 02 (36C242) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24226N0689 | CENTRAL TOX LLC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $79,995 | FY2026 |
| 36C24226N0614 | LABORATORY CORPORATION OF AMERICA | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $2,352,838 | FY2026 |
| 36C24226A0050 | LABORATORY CORPORATION OF AMERICA | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $0 | FY2026 |
| 36C24226N0607 | QUEST DIAGNOSTICS INCORPORATED | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $675,002 | FY2026 |
| 36C24226N0524 | WYOMING COUNTY COMMUNITY HOSPITAL | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $19,400 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24220N0189_3600_VA24217D0053_3600 · retrieved 2026-09-26.